Control versus cognition: the changing paradigm of adjuvant therapy for resected brain metastasis

Twenty years ago, Patchell and colleagues¹ demonstrated that whole-brain radiotherapy (WBRT) mitigates relapse both in the surgical bed and elsewhere in the brain and prevents death from neurologic causes in patients with resected brain metastasis. Therefore, postoperative WBRT became the standard of care.